Harald Wagner

Title: Innovations by Harald Wagner: Pioneering Abuse-Deterrent Pharmaceutical Solutions

Introduction

Harald Wagner, an esteemed inventor based in Graz, Austria, has made significant contributions to the field of pharmaceuticals. With a focus on creating compositions aimed at reducing drug abuse potential, his work reflects a commitment to public health and safety. He holds two patents that showcase his innovative approach to drug formulation.

Latest Patents

Wagner's latest patents involve the development of abuse-deterrent pharmaceutical compositions. The first patent details a composition that includes a drug featuring an enzyme-reactive functional group alongside an enzyme capable of reacting with this group. This formulation is designed to maintain the drug in a stable, enzyme-reactive state, preventing any enzymatic activity that could lead to misuse. The second patent further explores this concept, specifically focusing on oxycodone and its corresponding processing enzyme, establishing a method to keep both components in a stable state that minimizes abuse potential. These innovations are crucial in combating the misuse of prescription medications.

Career Highlights

Harald Wagner is associated with G.L. Pharma GmbH, where he develops pharmaceutical innovations aimed at improving drug safety. His career reflects a dedication to advancing the pharmaceutical field through research and development, particularly in creating formulations that discourage drug abuse.

Collaborations

Throughout his career, Wagner has collaborated with notable colleagues, including Georg Guebitz and Katrin Greimel. Their collective expertise has fostered a research environment geared towards innovation and effective pharmaceutical solutions, exemplifying the power of teamwork in achieving groundbreaking inventions.

Conclusion

In conclusion, Harald Wagner's work in developing abuse-deterrent pharmaceutical compositions underscores his vital role in enhancing drug safety. With two patents to his name, his contributions continue to shape the future of pharmaceuticals, providing crucial advancements that aim to mitigate the risks associated with drug abuse.